PAI Is Said to Prepare $1.2 Billion Sale of Drugmaker Ethypharm

Private equity firm PAI Partners is exploring a sale of French drugmaker Ethypharm, a specialist in pain and addiction treatment, according to people familiar with the matter....

Redirecting to full article...